JEAN BAHU: Open Payments
NPI 1669869954 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 21 payments from 9 companies in 2025. Trend: 2023 $1,243 · 2024 $901 · 2025 $472
Food & beverage: $397Education: $75
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $126 |
| Janssen Biotech, Inc. | 2 | $105 |
| ABBVIE INC. | 4 | $78 |
| LEO Pharma Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Incyte Corporation | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| UCB, Inc. | 1 | $17 |
Products named: COSENTYX, TREMFYA, SKYRIZI, ANZUPGO, Sotyktu, OPZELURA, RINVOQ, DUPIXENT.
Industry payments across IN — which companies pay providers there.
